Kaizen Pharmaceuticals Secures Approval for Cytotoxic Dry Powder Injectables

Kaizen Pharmaceuticals, setting new standards in "Oncology Care" in Pakistan through its advanced, high-tech manufacturing facility, is proud to have received approval to manufacture Cytotoxic Dry Powder Injectables (Cancer Care). This is a defining moment for Kaizen Pharmaceuticals and a major stride toward strengthening Pakistan's Oncology supply while reducing reliance on imported cancer treatments. Producing these life-saving injectables locally will make quality oncology medicines affordable & more reliably available to the patients, all while meeting the rigorous facility, containment, and quality standards that cytotoxic manufacturing demands. A hard-earned achievement by our entire Kaizen Pharma team, and one we'll keep building on for a healthier future in Pakistan.